In This Section


Here’s a look at the 2018 exhibitors who showcased at the ACCC 35th National Oncology Conference. If you are interested in exhibiting or reserving a booth space at a future meeting or conference, please contact Mal Milburn, Exhibit Manager, at 301.984.5074 or email



logo-abbvie-200x80 Corporate Member
Booth: 101

1 North Waukegan Road
North Chicago, IL 60064

At AbbVie, we strive to discover and develop medicines that deliver transformational improvements in cancer treatment. We remain focused on delivering transformative advances in treatment across some of the most debilitating and widespread cancers. AbbVie’s oncology portfolio consists of marketed medicines and a pipeline containing multiple new molecules being evaluated worldwide in more than 200 clinical trials and 20 different tumor types.

Adaptive Biotechnologies

Booth: 105
1551 East Lake Avenue E
Suite 200
Seattle, WA 98102

Adaptive is pioneering the use of immunosequencing to revolutionize patient care. We translate the scale and precision of the adaptive immune system into products to diagnose and treat disease.


Corporate Member
Booth: 513

One Amgen Center Drive
Thousand Oaks, CA 91320


Array Biopharma, Inc.

Booth: 411
23200 Walnut Street
Boulder, CO 80301



Practice Support
Booth: 413

2318 Mill Road, Suite 800
Alexandria, VA 22314

ASCO’s Practice Support services are your one-stop shop for the operations side of cancer care, from educational resources and practical tools to transition your practice to a value-based reimbursement system, to data and information to enhance your business operations and quality of care. ASCO’s Clinical Affairs team is here to provide the educational tools, training programs, services, and resources you need to deliver high-quality, high-value care to your patients. Visit our booth to learn more about available resources and programs!

Association of Cancer Executives

Booth: 601
1000 Potomac Street, NW, Suite 108
Washington, DC 20007


Association of Oncology Social Work

Booth: 604
One Parkview Plaza, Suite 800
Oakbrook, IL 60181



AstraZeneca_200x80 Corporate Member
Booth: 103

One Medimmune Way
Gaithersburg, MD 20876

Helping patients access the care they need.

The AstraZeneca Access 360™ program provides personal support to connect patients to affordability programs and streamline access and reimbursement for select AstraZeneca medicines. Access 360 provides:

  • Assistance with understanding patient insurance coverage and pharmacy options
  • Prior authorization support
  • Claims and appeals process support

To learn more about the AstraZeneca Access 360 program, please call 1.844.ASK.A360 (1.844.275.2360) Monday – Friday 8 AM – 8 PM or visit


AstraZeneca_200x80 Corporate Member
Booth: 612

13710 E. Leisure Lane
Scottsdale, AZ 85262

Products: Imfinzi, Tagrisso, Calquence, Faslodex, Lynparza.


Corporate Member
Booth: 502

100 Bayer Blvd.
Whippany, NJ 07981

Bayer is a global enterprise with core competences in the life science fields of healthcare and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the group aims to create value through innovation, growth, and high-earning power.

Boehringer Ingelheim Pharmaceuticals, Inc.

Corporate Member
Booth: 403

900 Ridgebury Road
Ridgefield, CT 06877

Through scientific innovation and collaboration, Boehringer Ingelheim is committed to discovering and developing novel anti-cancer agents that address unmet needs across a broad range of solid and hematological malignancies. As part of our unique research approach, we seek out strong partnerships and remain dedicated to delivering treatments that improve cancer patients’ lives.

Bristol-Myers Squibb

Corporate Member
Booth: TBD

3401 Princeton Pike
Lawrence, NJ 08648

Bristol-Myers Squibb is committed to providing universal access to all our medicines. We understand that we have an important role to play, first and foremost by developing treatments that address unmet medical needs, and also by working with payers, physicians, patients and civil society to enhance access.

Celgene Corporation

Corporate Member
Booth: 204

86 Morris Avenue
Summit, NJ 07901

Celgene Corporation (Nasdaq:CELG) is a global biopharmaceutical company that is helping healthcare providers turn incurable cancers into chronic, manageable diseases, as well as manage serious inflammatory conditions through innovative therapies. This dedication to medical progress goes hand-in-hand with our industry-leading patient support and access programs. Together, these aspects form the core of our commitment to patients worldwide. For more information, visit

Champion Manufacturing Inc.

Booth: 208
2601 Industrial Pkwy.
Elkhart, IN 46516


CHAMPS Oncology

Booth: 312
1226 Huron Road East
Cleveland, OH 44115

Discover the power of your cancer registry data through CHAMPS Oncology’s cloud-based analytics system, which transforms your cancer data into actionable information. Insight2oncology® offers 100+ customizable reports containing dashboards and patient-origin mapping in areas including migration, utilization, disease sites, and community. Learn more at or stop by booth 312 for a demo.

Chartis Oncology Solutions

Booth: 505
150 E. Ponce de Leon Avenue, Suite 400
Decatur, GA 30030


Coherus BioSciences

Booth: 307
333 Twin Dolphin Drive, Suite 600
Redwood City, CA 94065

Developing oncology biosimilars.

Constant Media

Booth: 202
155 Willowbrook Blvd., Suite 460
Wayne, NJ 07470

Constant Media connects patients and caregivers with relevant health and wellness information at the point of care. We're committed to arming patients and healthcare providers (HCPs) with the latest and most trusted health ed. Our media assets are designed to improve patient/physician dialogue, treatment therapies, and drug adherence in an attempt to inspire lifestyle change that can lead to better health outcomes and disease management.

CVS Specialty

Booth: 511
1 CVS Drive
Woonsocket, RI 02895


Eisai, Inc.

Corporate Member
Booth: 501

100 Tice Boulevard
Woodcliff Lake, NJ 07677

As the U.S pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we are a fully-integrated pharmaceutical business with discovery, clinical, manufacturing, and marketing capabilities. Our key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases). To learn more about Eisai, Inc., please visit us at and follow us on Twitter and LinkedIn.

Eli Lilly and Company

Corporate Member
Booth: 401

Lilly Corporate Center
Indianapolis, IN 46285

For more than 50 years, Lilly Oncology has been delivering life-changing medicines and support to people living with cancer and those who care for them. We are determined to build on this heritage and continue making life better for those affected by cancer around the world.

What makes us unique
Lilly Oncology is committed to developing a broad portfolio of therapies and meaningful support solutions that accelerate the pace and progress of cancer care. Our hope is to optimize patient outcomes and find meaningful and practical ways to support patients, caregivers, and the care team throughout the cancer journey.

Our research is focused in 3 key areas: tumor cell signaling, microenvironment, and immune-oncology.

Exelixis, Inc.

Corporate Member
Booth: 509

210 East Grand Avenue
South San Francisco, CA 94080

Exelixis is on a Mission to Help Cancer Patients Recover Stronger and Live Longer

Exelixis is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. We have three commercially available products, CABOMETYX® (cabozantinib), COMETRIQ® (cabozantinib) and COTELLIC® (cobimetinib).


logo-GeneMatters-320x67 Booth: 306
807 Broadway St NE
Suite #350
Minneapolis MN, 55413

GeneMatters offers telehealth genetic counseling to expand your services to patients. As a partner to cancer programs, we provide cost-effective access to board-certified genetic counselors with deep oncology experience and rigorous quality measures to meet CoC and NAPBC standards. Tailor our service and online platform to easily integrate for scheduling, patient management and record-sharing. Let’s improve access together.


Corporate Member
Booth: 102

1 DNA Way
South San Francisco, CA 94083

Product: Venclexta.


Corporate Member
Booth: 305

1 DNA Way
South San Francisco, CA 94083

For more than 40 years, we’ve been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions. We are headquartered in South San Francisco, California.


Booth: 209
2131 Faraday Avenue
Carlsbad, CA 92008

Genoptix is one of the largest hematopathology centers in the U.S. and is a leading clinical oncology laboratory specializing in hematology and solid tumors. Located in Carlsbad, California, with a staff of over 400, and occupying over 27,000 square feet of laboratory space, Genoptix’s modern facilities are well-suited to handle the large volume of samples that enters its doors each day.

Heron Therapeutics

logo-HeronTherapeutics-159x80 Corporate Member
Booth: 410

4242 Campus Point Cove, Suite 200
San Diego, CA 92121

Heron Therapeutics aims to develop patient-focused solutions by applying our innovative science and technologies with well-known pharmacology.

Our product portfolio includes the following:

  • SUSTOL® (granisetron) extended-release injection is a serotonin-3 (5-HT3) receptor antagonist that is approved by the U.S. Food and Drug Administration (FDA) and is indicated in combination with other antiemetics in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens.
  • CINVANTI® (aprepitant) injectable emulsion, for intravenous use is a substance P/neurokinin-1 (NK1) receptor antagonist that is approved by the FDA and is indicated in adults, in combination with other antiemetic agents, for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin and nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).
  • HTX-011 (bupivacaine and meloxicam) is an investigational drug that has not been approved by the FDA or other international regulatory authority. It is a fixed-dose combination of the local anesthetic bupivacaine with the nonsteroidal anti-inflammatory drug (NSAID) meloxicam. Inclusion of low-dose meloxicam in HTX-011 reduces local inflammation and reverses the acidic environment caused by surgery, allowing enhanced penetration of bupivacaine into the nerves and thereby potentiating its effect. HTX-011 is in development for application into the surgical site to reduce postoperative pain and the need for opioid analgesics for 72 hours. It was granted Fast Track Designation from the FDA in the fourth quarter of 2017 and Breakthrough Therapy Designation from the FDA in the second quarter of 2018. Heron released positive Topline Phase 3 Results for HTX-011 in the EPOCH 1 study (bunionectomy) and the EPOCH 2 study (hernia repair) and positive Topline Phase 2b Results for HTX-011 in subjects undergoing total knee arthroplasty and breast augmentation. In the second half of 2018, Heron expects to submit an NDA to the FDA for HTX-011.
Incyte Corporation

Corporate Member
Booth: 300

1801 Augustine Cut-off
Wilmington, DE 19803

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics, primarily for oncology. For additional information on Incyte, please visit the company’s website at Follow @Incyte on Twitter.

Integrated Oncology

Booth: 213
3400 Computer Drive
Westborough, MA 01581

Integrated Oncology, a member of LabCorp’s Specialty Testing Group, provides comprehensive pathology, molecular, and genomic testing to aid clinicians in the treatment of cancer across the entire continuum of care. Our test menu is coupled with extensive managed care contracts and robust connectivity and logistics solutions to ensure the broad access for patients to impactful diagnostic information. Additionally, multiple locations in the Integrated Oncology national network have achieved the rigorous CAP 15189 ISO accreditation.

Ipsen Biopharmaceuticals

Corporate Member
Booth: 304

106 Allen Road, 3rd Floor
Basking Ridge, NJ 07920

Ipsen has two oncology products:

  • Somatuline Depot (lanreotide) injection
  • Onivyde (irinotecan liposome injection)
Janssen Oncology

Corporate Member
Booth: 408

800 Ridgeview Drive
Horsham, PA 19044


Kite, a Gilead Company

Booth: 107
2400 Broadway
Santa Monica, CA 90404

Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early research to product development.

For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, changing the paradigm of cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago.

With an unrelenting drive and a singular focus on cell therapy, our team is executing on our strategy to bring life-saving therapies to patients.


logo-LeanTaaS-329x80Booth: 507
469 El Camino Real, #220
Santa Clara, CA 95050

iQueue for Infusion Centers uses lean methodologies to create optimized scheduling templates to maximize patient flow and chair usage.

Booth: 508
2655 Northwinds Pkwy
Alpharetta, GA 30009

Our mission is to improve healthcare by providing patients with access to quality medical care through innovative staffing solutions.

Why do we do what we do? Because we're committed to patient care. At the end of the day, we work to make sure patients have access to the medical care they need.

McKesson and the US Oncology Network

logo-McKessonUSON-400x80Booth: 210
One Post Street
San Francisco, CA 94104
McKesson Specialty Health

McKesson works together with stakeholders across the healthcare delivery system to protect and strengthen the delivery of oncology care close to home. Through innovative solutions, McKesson helps providers increase profitability and efficiency through group purchasing contracts, inventory management, expert consulting to improve cash flow and reimbursement, MIPS/MACRA education and more. At McKesson, we believe that we are all in this together.


Booths: 311 & 313
6975 S. Union Park Ctr., Suite 500
Cottonwood Heights, UT 84074


Merck & Co., Inc.

Booth: 503
2000 Galloping Hill Road
Kenilworth, NJ 07013

Product: Keytruda.

Mylan, Inc.

Booth: 602
1000 Mylan Blvd.
Canonsburg, PA 15317

Mylan is a global pharmaceutical company committed to setting new standards in healthcare and providing the world’s 7 billion people access to high quality medicine. We offer a growing portfolio of more than 7,500 products including prescription generic, branded generic, brand-name drugs and over-the-counter remedies. We market our products in more than 165 countries and territories. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world.

Navigating Cancer

Booth: 308
1008 Western Avenue, Suite 206
Seattle, WA 98104

Oncology-specific software platform, Navigating Cancer is the pioneer in patient relationship management software for cancer care. By providing each staff member with a real-time patient view to improve care coordination, the platform streamlines the care team so they can spend less time on administrative work and more time on care delivery.

Novartis Oncology

Corporate Member
Booth: 212

One Health Plaza, Building 335
East Hanover, NJ 07936

At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

Oncology Convergence

Booth: 610
8950 South 52nd Street
Suite 101
Tempe, AZ 85284

We Help You Work Smarter
The OCI team focuses on oncology reimbursement, management, and technology. Oncology Convergence, Inc. (OCI) has one of the most specialized teams in the industry. OCI combines clinical and financial experience to assist and guide oncology practices to maximize profits without sacrificing patient care, time or compliance. Our managers and staff have an average of 15 years of experience in Radiation Oncology, Medical Oncology, Gynecologic Oncology, Pediatric Oncology, Clinical Research and Diagnostic Imaging. OCI is proud to announce that they have received their SSAE16 level one certification, which makes us one of the only oncology management or billing companies to meet this standard and level of proven quality and security.

Oncology Management Consulting Group

Booth: 412
4532 West Kennedy Blvd., Suite 284
Tampa, FL 33609

Supporting cancer centers and physician practices—both infusion and radiation oncology—Oncology Management Consulting Group offers the most comprehensive line of consulting services in the industry. Our oncology specialists remain on the cutting edge with assistance that includes strategic planning, operational assessments, hospital/physician alignment, interim management, in-depth revenue cycle reviews, business planning, and so much more.

PAN Foundation

Booth: 504
805 15th Street, NW, Suite 500
Washington, DC 20005

The Patient Access Network (PAN) Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially-insured people living with life-threatening, chronic, and rare diseases with the out-of-pocket costs for their prescribed medications. Partnering with generous donors, healthcare providers, and pharmacies, PAN provides the underinsured population access to the healthcare treatments they need to best manage their conditions and focus on improving their quality of life. Since its founding in 2004, PAN has provided nearly 1 million underinsured patients with over $3 billion in financial assistance, through close to 70 disease-specific programs.

PAN has an administrative fee of only 5%. This means that $0.95 of every dollar PAN receives goes directly toward helping patients. For the last eight years, PAN spent less than one penny of each dollar it received on fundraising.


Booth: 606
5901 E. Galbraith Road
Suite R1000
Cincinnati, OH 45236

PatientPoint pioneered the point-of-care marketing industry, revolutionizing patient education. 30 years later, we are still trusted to offer the most innovative, completely customized and targeted solutions to reach patients and providers when and where it matters most.

Patient Resource, LLC

Booth: 309
8455 Lenexa Drive
Overland Park, KS 66214

Patient Resource’s personalized cancer navigation and patient education platform provides medical professionals with the tools needed to personally guide each patient’s experience from the first appointment—throughout treatment—and on to long-term survivorship. The platform provides on-demand qualitative reporting features and can assist with meeting accreditations.


Booth: 603
995 E. Arques Avenue
Sunnyvale, CA 94085

Pharmacyclics, an AbbVie company, is located in Sunnyvale, California, and is focused on developing and commercializing innovative small-molecule therapies for the treatment of certain cancers and immune-mediated diseases. Our hope is that we can change or improve the standard of care for the disease areas we treat or study to continually advance cancer care for patients.

Pfizer Oncology

Corporate Member
Booth: 500

235 E. 42nd Street
New York, NY 10017

Pfizer Oncology is committed to the discovery, investigation, and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline of biologics and small molecules—one of the most robust in the industry—is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers. By working collaboratively with academic institutions, individual researchers, cooperative research groups, governments, and licensing partners, Pfizer Oncology strives to cure or control cancer with breakthrough medicines to deliver the right drug for each patient at the right time. For more information please visit

Puma Biotechnology

Booth: 302
701 Gateway Blvd., 5th Floor
South San Francisco, CA 94080

Puma is dedicated to advancing the treatment of HER2+ breast cancer and supporting women, their families, and the breast cancer community.

Radiation Business Solutions

Booth: 304
1044 Jackson Felts Road
Joelton, TN 37080

Radiation Business Solutions creates value for oncology programs while creating a better financial experience for cancer patients. Since 2004, we’ve provided oncology-specific strategies to physicians and hospital-based programs, including total revenue cycle management, patient experience programs, referral optimization services, and new cancer center development.


Booth: 510
777 Old Saw Mill River Road
Tarrytown, NY 10591

Regeneron (NASDAQ: REGN) is a leading science and technology company delivering life-transforming medicines for serious diseases.

Founded by physician-scientists 30 years ago, our science-driven approach has resulted in six FDA-approved medicines and numerous product candidates in a range of diseases, including asthma, pain, cancer and infectious diseases.

Revenue Cycle Inc.

Booth: 512
1501 Volta Drive, Suite 100
Cedar Park, TX 78641

Revenue Cycle is a full-service oncology consulting firm delivering customized, leading-edge, comprehensive services and educational resources to healthcare providers who are in hospital-based, private practice, or freestanding cancer centers. Our services include medical records review, compliance, education and training, billing and coding, remote solutions, and revenue cycle management solutions.

Roche Diagnostics

Booths: 205 & 207
9115 Hague Road
Indianapolis, IN 46250

A software solution for managing tumor boards and aligning oncology care teams on treatment decisions, hosted on secure and compliant cloud infrastructure.


Booth: 600
1500 Rosecrans Avenue, Suite 500
Manhattan Beach, CA 90266

RxVantage is a free tool used by thousands of medical practices. It simplifies finding reps and allows them to schedule appointments directly in custom online calendars, saving hours of administrative time that could be devoted to clinical care. RxAssist aggregates patient assistance programs, providing patients with vouchers for products and services.

Sandoz Biopharmaceuticals

Corporate Member
Booth: 404

100 College Road West
Princeton, NJ 08540

Sandoz is a global leader in generic and biosimilar medicines, committed to playing a leading role in driving access to medicine worldwide. In 2015, Sandoz launched the first biosimilar, Zarxio, in the United States.

Seattle Genetics

Corporate Member
Booth: 310

21823-30th Drive S.E.
Bothell, WA 98021

Seattle Genetics is the largest global oncology biotechnology company based in the Pacific Northwest. We are focused on developing and commercializing a new generation of targeted, empowered antibody-based therapies that have the potential to change the foundation of treatment for people with cancer.

We have one marketed product, ADCETRIS® (brentuximab vedotin), which is the first in a new class of ADCs, commercially available in more than 65 countries worldwide for relapsed classical Hodgkin lymphoma (HL) and relapsed systemic anaplastic large cell lymphoma (sALCL).


Booth: Lobby Area
1086 Teaneck Road, Suite 2G
Teaneck, NJ 07666

Sharsheret is a national non-profit organization that supports women and families, of all Jewish backgrounds, facing breast cancer, at every stage - before, during, and after diagnosis.

Sharsheret works with cancer centers across the country to provide free educational resources for patients and offer cultural competency training to healthcare providers.

Spectrum Pharmaceuticals

Booth: 113
11500 S. Eastern Avenue, Suite 240
Henderson, NV 89052

Spectrum Pharmaceuticals is a commercial-stage biotechnology Company with fully integrated commercial and drug development operations, and a leader in hematology/oncology.

Our primary strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products.

Spectrum has three drugs in advanced development:

  • Poziotinib for patients with a mutation in Non Small Cell Lung Cancer (NSCLC), and for patients with breast cancer.
  • Eflapegrastim, being developed for chemotherapy-induced neutropenia in patients with breast cancer.
  • Apaziquone for Intravesical Instillation, being developed for immediate intravesical instillation post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer.
Taiho Oncology, Inc.

Corporate Member
Booth: 409

202 Carnegie Center
Princeton, NJ 08540

Taiho Oncology, Inc. (, a division of Taiho Pharmaceuticals Co., Ltd., and Otsuka Holdings Co., Ltd., has established a world class clinical development organization that works urgently to develop innovative cancer treatments and has built a commercial business in the U.S. Taiho has an oral oncology pipeline consisting of both novel antimetabolic agents and selectively targeted agents.


Booth: 608
30100 Telegraph Road
Bingham Farms, Michigan 48025
(800) 910-9801

TailorMed brings the most comprehensive financial navigation platform in the market, providing an end-to-end solution to healthcare organization. The platform harnesses technology to improve the financial performance of healthcare providers and reduce the financial hardship for patients .

Takeda Oncology

Corporate Member
Booth: 407

40 Landsdown Street
Cambridge, MA 02139

We endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation, and passion for improving the lives of patients.


Tesaro-200x80 Corporate Member
Booth: 506

1000 Winter Street North, Suite 3300
Waltham, MA 02451

TESARO is a biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. We see new possibilities to responsibly develop and commercialize innovative treatments where others may not. Relationships are vital to the success of our business, and we are committed to being a trusted partner to the cancer community. For more information, please visit

TEVA Oncology

Corporate Member
Booth: 201

41 Moores Road
Frazer, PA 19355

Teva Oncology is a top U.S. oncology company that strives to improve the lives of people affected by cancer. Our focus is to provide solutions in hematologic malignancies, solid tumors, and supportive care. Teva Oncology's vision is to change the course of cancer care one patient at a time.

TSK Products

Booth: 201
12 Windsor Drive
Eatontown, NJ 07724

Ensuring safety and comfort with both UV disinfection of infusion clinics and infusion seating that aims to make treatment comfortable.

Unlimited Systems

logo-UnlimitedSystems-476x80Booth: 206
5905 East Galbraith Road
Suite 8000
Cincinnati, OH 45246

Unlimited Systems equips cancer specialist providers with the industry-leading g4-Centricity revenue cycle platform.  Our software simplifies management of complex financial transactions, delivers features valued by Institutional service lines and Freestanding centers, and guides effective and efficient financial workflow at the point of service as well as across the business office.

Verastem Oncology

Booth: 211
117 Kendrick Street, Suite 500
Needham, MA 02494

Verastem Oncology is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients. Verastem Oncology is currently developing duvelisib, a dual inhibitor of PI3K-delta and PI3K-gamma, and defactinib, a focal adhesion kinase (FAK) inhibitor. Verastem Oncology’s product candidates seek to treat cancer by modulating the local tumor microenvironment and enhancing anti-tumor immunity. For more information, please visit

Via Oncology

Booth: 507
1251 Waterfront Place, 5th Floor
Pittsburgh, PA 15222

Via Oncology’s mission is to improve outcomes for patients with cancer by providing evidence-based clinical pathways, decision support software, OMH tools, and analytics for medical, radiation, and surgical oncology. Via Pathways are developed with a consistent, inclusive, and transparent process that incorporates the voices of the physicians who use them.


Booth: 203
115 E 23rd Street, Floor 5
New York, NY 10010



Corporate Member
Booth: 405

200 Wilmot Road
Deerfield, IL 60015

Walgreens is dedicated to serving the needs of patients living with complex, chronic, and rare health and medical conditions. Our team of oncology-focused pharmacists, nurses, and care coordinators assist healthcare providers and patients in obtaining medications, coordinating insurance benefits, maintaining medication adherence, managing side effects, and providing refill assistance.